PT1030686E - Liofilizado de complexo lipidico de porfirinas insoluveis em agua - Google Patents

Liofilizado de complexo lipidico de porfirinas insoluveis em agua

Info

Publication number
PT1030686E
PT1030686E PT98903356T PT98903356T PT1030686E PT 1030686 E PT1030686 E PT 1030686E PT 98903356 T PT98903356 T PT 98903356T PT 98903356 T PT98903356 T PT 98903356T PT 1030686 E PT1030686 E PT 1030686E
Authority
PT
Portugal
Prior art keywords
porfirins
insoluve
water
complex
lyophilized
Prior art date
Application number
PT98903356T
Other languages
English (en)
Inventor
Mathew Cherian
Shireesh Prakash Apte
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PT1030686E publication Critical patent/PT1030686E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT98903356T 1997-01-28 1998-01-28 Liofilizado de complexo lipidico de porfirinas insoluveis em agua PT1030686E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78956697A 1997-01-28 1997-01-28

Publications (1)

Publication Number Publication Date
PT1030686E true PT1030686E (pt) 2004-06-30

Family

ID=25148009

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98903356T PT1030686E (pt) 1997-01-28 1998-01-28 Liofilizado de complexo lipidico de porfirinas insoluveis em agua

Country Status (9)

Country Link
EP (1) EP1030686B1 (pt)
JP (1) JP2001511128A (pt)
AT (1) ATE261736T1 (pt)
AU (1) AU6015298A (pt)
DE (1) DE69822496T2 (pt)
DK (1) DK1030686T3 (pt)
ES (1) ES2218805T3 (pt)
PT (1) PT1030686E (pt)
WO (1) WO1998032463A2 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
EA200601630A1 (ru) * 2004-03-04 2007-02-27 Макото Юаса Ниосома, имеющая внедрённый в неё маталлопорфириновый комплекс, способ её получения и лекарственное средство с её использованием
JP4591820B2 (ja) * 2005-01-31 2010-12-01 株式会社ケムコ 化学発光試薬
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
DE602007009377D1 (de) 2006-05-30 2010-11-04 Intarcia Therapeutics Inc Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
US7682356B2 (en) 2006-08-09 2010-03-23 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies for use therein
JP5351884B2 (ja) 2007-04-23 2013-11-27 インターシア セラピューティクス，インコーポレイティド インスリン分泌促進性ペプチドの懸濁製剤及び使用
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
HUE035862T2 (en) 2009-09-28 2018-05-28 Intarcia Therapeutics Inc Rapid development and / or completion of substantially steady-state drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
JP6190534B2 (ja) 2013-08-22 2017-08-30 ソニー株式会社 水溶性蛍光染料又は有色染料及びその使用方法
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
ES2968262T3 (es) 2015-06-03 2024-05-08 I2O Therapeutics Inc Sistemas de colocación de implantes
AU2017240154B2 (en) 2016-04-01 2021-08-12 Sony Group Corporation Ultra bright dimeric or polymeric dyes
JP7071286B2 (ja) 2016-05-11 2022-05-18 ソニーグループ株式会社 超明色ダイマーまたはポリマー染料
WO2017200943A1 (en) 2016-05-16 2017-11-23 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
US12018159B2 (en) 2016-07-29 2024-06-25 Sony Group Corporation Ultra bright dimeric or polymeric dyes and methods for preparation of the same
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法
JP7403744B2 (ja) * 2017-10-05 2023-12-25 ソニーグループ株式会社 プログラマブルな樹枝状薬物
KR20200083605A (ko) 2017-11-16 2020-07-08 소니 주식회사 프로그램가능한 중합체성 약물
US11874280B2 (en) 2018-03-19 2024-01-16 Sony Group Corporation Use of divalent metals for enhancement of fluorescent signals
US12006438B2 (en) 2018-06-27 2024-06-11 Sony Group Corporation Polymeric dyes with linker groups comprising deoxyribose
CN113383043A (zh) 2019-09-26 2021-09-10 索尼集团公司 具有连接体基团的聚合物串联染料

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2047969A1 (en) * 1990-08-17 1992-02-18 Thomas D. Madden Benzoporphyrin vesicles
US5277913A (en) * 1991-09-09 1994-01-11 Thompson David H Liposomal delivery system with photoactivatable triggered release
CA2087902C (en) * 1992-02-05 2006-10-17 Narendra Raghunathji Desai Liposome compositions of porphyrin photosensitizers
GB9500116D0 (en) * 1995-01-05 1995-03-01 Ciba Geigy Ag Pharmaceutical compositions
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US5707608A (en) * 1995-08-02 1998-01-13 Qlt Phototherapeutics, Inc. Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer

Also Published As

Publication number Publication date
ES2218805T3 (es) 2004-11-16
DE69822496T2 (de) 2005-03-03
EP1030686A2 (en) 2000-08-30
DE69822496D1 (de) 2004-04-22
JP2001511128A (ja) 2001-08-07
AU6015298A (en) 1998-08-18
EP1030686B1 (en) 2004-03-17
WO1998032463A2 (en) 1998-07-30
ATE261736T1 (de) 2004-04-15
WO1998032463A3 (en) 1998-10-22
DK1030686T3 (da) 2004-04-13

Similar Documents

Publication Publication Date Title
PT1030686E (pt) Liofilizado de complexo lipidico de porfirinas insoluveis em agua
ES2153665T3 (es) Usos terapeuticos de productos proteicos bactericidas/incrementadores de la permeabilidad (bpi) para la meningococemia humana.
AU2210899A (en) Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers
NO965454D0 (no) Diatrizoksy ester som röntgen kontrastmidler for billeddannelse av blod og lymfesystem
ES2216055T3 (es) Metodos para reducir o mantener niveles reducidos de lipidos en sangre usando composiciones de proteina ob.
NO20003051D0 (no) Metode for administrering av AspB28-humant insulin
IL112667A (en) 6-substituted derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
BR9506820A (pt) Derivados de 4-amino de ácido micofenólico
MY113203A (en) Lyophilizate of lipid complex of water insoluble camptothecins
HK1030885A1 (en) The use of isatin and oxindole derivatives in the preparation of a medicament for use in the treatment of mycobacterial disease
NO20002827D0 (no) Anvendelse av fosfolipidkomplekser av Vitis vinifera som antiaterosklerotiske midler
ATE103804T1 (de) Pharmazeutische praeparate.
ZA984268B (en) Method and composition for administering taxanes orally to human patients
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
DE69817379D1 (de) Pharmazeutische zubereitungen enthaltend ibuprofen und domperidon zur behandlung von migräne
NO20014812L (no) Fremgangsmate for tilveiebringelse av kosmetisk/medisinsk terapi
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
WO1998036778A8 (en) Sustained drug delivery and compositions useful therefor
NO984198L (no) FremgangsmÕte for behandling av aggresjon
IL153867A0 (en) Pharmaceutical preparation for the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma
HU9801869D0 (en) Pharmaceutical composition for enhancing level of l-carnitin in human patients